NCT06764615View on ClinicalTrials.gov

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

PHASE2RecruitingINTERVENTIONAL

Enrollment

183

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

December 30, 2029

Study Completion Date

December 30, 2029

Conditions

Crohn's DiseaseUlcerative Colitis

Interventions

DRUG

Zasocitinib

Zasocitinib capsules.

Trial Locations (1)

75701

RECRUITING

Tyler Research Institute, LLC, Tyler

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY

NCT06764615 - A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) | Biotech Hunter | Biotech Hunter